CINCINNATI, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address ...
Pneumonia remains one of the leading causes of death in low- and middle-income countries, where access to advanced medical ...
- Development of Intercell's Streptococcus pneumoniae vaccine supported by PATH VIENNA, April 7 /PRNewswire/ -- Intercell AG (VSE: ICLL) announced today that a Phase I clinical trial with the ...
CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Affinivax, Inc. ("Affinivax") and Astellas Pharma Inc. (“Astellas”) announced results from the Phase 2 clinical trial of ASP3772, a novel vaccine candidate ...
In a recent study posted to the medRxiv* preprint server, researchers investigate the effect of colonization of the upper respiratory tract (URT) by Streptococcus pneumoniae on severe acute ...
Bacterial colonization in the upper respiratory tract is considered to be one of the major risk factors of COVID-19. In this context, studies have shown that the co-occurrence of invasive pneumococcal ...
Streptococcus pneumoniae fructose bisphosphate aldolase (FBA) is a cell wall-localized lectin. We demonstrate that recombinant (r) FBA and anti-rFBA antibodies inhibit encapsulated and unencapsulated ...
Pneumococcal disease poses a severe risk to Indian adults, particularly those with chronic health issues. Despite effective ...
Researchers have found a further reason for the severity of dual infection by influenza and Streptococcus pneumonia -- a new virulence mechanism for a surface protein on the pneumonia-causing bacteria ...
Bacteria inflaming the meninges have developed an immunosuppressive mechanism that contributes to their ability to attack the brain. Researchers found that, by activating pain receptors (nociceptors) ...
A Pennsylvania teenager has died from bacterial meningitis, months before graduating from high school, according to the school district. Ryan Duffy, 18, was a senior at Neshaminy High School in ...
Initiation of a first-in-man Phase I clinical trial in healthy subjects Study aims to obtain safety and immunogenicity data of this new vaccine candidate Initial results expected in Q4 2009 ...